Loading organizations...
Truetide plc, formerly Braveheart Investment Group plc, functions as a UK-based investment company. It deploys capital into both unlisted and listed enterprises, with a primary focus on identifying and fostering technology businesses that demonstrate significant growth potential and value creation. The firm's investment strategy is centered on achieving long-term development for its portfolio.
Operating since 1997, the company's establishment stemmed from a fundamental understanding of the capital demands faced by emerging businesses, particularly those poised for substantial market expansion. This consistent, decades-long pursuit of strategic investments underscores its dedication to nurturing high-potential ventures across diverse stages of development.
Truetide serves as a key financial and strategic partner for its portfolio companies, providing essential capital for their expansion. Its vision is to cultivate a robust portfolio of high-growth technology firms, generating enduring value for its stakeholders and driving innovation within the UK and global markets.
Braveheart Investment Group has 2 tracked investments across 1 company. The latest tracked deal is $27.0M Series B in Binx Health in July 2011.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 1, 2011 | Binx Health | $27.0M Series B | — | Earlybird Venture Capital, EQT Life Sciences, HealthCap, OrbiMed, BB Biotech Ventures, Crescent, Johnson & Johnson Innovation, LSP, Novartis, Wyvern Asset Management, YFM Equity Partners |
| Feb 13, 2008 | Binx Health | $4.1M Other Equity | — | Finance South West, Geif, South West Ventures Fund, Swain Business Angel Network |
